Page last updated: 2024-08-20

dextrothyroxine and Angiogenesis, Pathologic

dextrothyroxine has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Cheng, L; Liu, J; Xu, T; Zhang, K; Zhu, H	1
Fang, S; Liu, B; Liu, Y; Sun, Q	1

Reviews

1 review(s) available for dextrothyroxine and Angiogenesis, Pathologic

Article	Year
Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin. Drug design, development and therapy, 2020, Volume: 14 Topics: Antineoplastic Agents; Cell Death; Cell Proliferation; Humans; Ivermectin; Mitochondria; Neoplasms; Neovascularization, Pathologic; Oxidative Stress	2020

Other Studies

1 other study(ies) available for dextrothyroxine and Angiogenesis, Pathologic

Article	Year
Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress. Biochemical and biophysical research communications, 2016, Nov-18, Volume: 480, Issue:3 Topics: Animals; Anthelmintics; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Glioblastoma; Humans; Ivermectin; Mice; Mice, SCID; Mitochondria; Neovascularization, Pathologic; Oxidative Stress; Treatment Outcome	2016

Article

Year

Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress.

Biochemical and biophysical research communications, 2016, Nov-18, Volume: 480, Issue:3

Topics: Animals; Anthelmintics; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Glioblastoma; Humans; Ivermectin; Mice; Mice, SCID; Mitochondria; Neovascularization, Pathologic; Oxidative Stress; Treatment Outcome

2016